Urea Cycle Disorders

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/82

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

83 Terms

1
New cards

What is the significance of the case presentation involving a 41-year-old female with a history of neonatal deaths?

The case highlights the potential for urea cycle disorders, as the mother has had two neonatal deaths and is now pregnant with a male fetus.

2
New cards

What symptoms did the male neonate exhibit on day 3 of life?

The neonate showed decreased oral intake, vomiting, lethargy, significant lethargy, and a full fontanelle.

3
New cards

What were the vital signs of the neonate at the time of examination?

Temperature: 35.5°C, Pulse: 150 bpm, Respiratory Rate: 90 breaths/min, Blood Pressure: 80/40 mmHg, O2 saturation: 99%.

4
New cards

What was the ammonia level found in the neonate's blood?

The ammonia level was 400 micromol/L.

5
New cards

What are common symptoms of hyperammonemia?

Symptoms include anorexia, vomiting, irritability, somnolence/lethargy, coma, death, and tachypnea.

6
New cards

What signs may indicate hyperammonemia?

Signs include respiratory alkalosis, low BUN, and a sepsis-like condition that does not improve despite the absence of other signs.

7
New cards

What are the normal ammonia levels for a newborn?

Normal ammonia levels for a newborn are 64-107 µmol/L.

8
New cards

How is the anion gap calculated, and what was the result in the vignette?

Anion gap is calculated as (Na - Cl - HCO3). In the vignette, it was 11, which is within the normal range (3-11).

9
New cards

What does a high anion gap with metabolic alkalosis suggest in this patient?

It suggests a urea cycle disorder.

10
New cards

What genetic causes of hyperammonemia do not present with acidosis?

Urea cycle disorders do not present with acidosis.

11
New cards

What testing is used to diagnose urea cycle disorders?

Testing includes plasma amino acids, urine orotic acid, and urine organic acids.

12
New cards

What are the unique aspects of Ornithine Transcarbamoylase (OTC) deficiency?

OTC deficiency is X-linked and can lead to elevated orotic acid levels.

13
New cards

What is the inheritance pattern of Argininosuccinic Acid Synthase (ASAS) deficiency?

ASAS deficiency is inherited in an autosomal recessive manner.

14
New cards

What are the potential consequences of hyperammonemia in infants?

Infants can develop permanent damage due to acute exposure to hyperammonemia.

15
New cards

What is the role of the urea cycle?

The urea cycle converts ammonia (NH3) from protein metabolism into urea for urinary excretion.

16
New cards

What is the relationship between protein intake and ammonia levels?

Increased protein intake can lead to elevated ammonia levels, particularly in patients with urea cycle disorders.

17
New cards

What are the symptoms of respiratory alkalosis in the context of hyperammonemia?

Symptoms may include tachypnea and altered mental status.

18
New cards

What is the typical presentation of infants with urea cycle disorders?

anorexia, vomiting

irritability,somnolence/lethargy,coma, death

tachypnea

disorientation, obtundation

respiratory alkalosis

Low BUN (blood urea nitrogen)

"sepsis" that doesn't improve despite lack of other signs

19
New cards

What is the significance of low BUN in the context of hyperammonemia?

Low BUN levels can indicate impaired urea cycle function, often seen in urea cycle disorders.

20
New cards

What are the potential complications of untreated hyperammonemia?

Untreated hyperammonemia can result in coma, death, and permanent neurological damage.

21
New cards

What is the role of N-Acetyl Glutamate Synthase (NAGS) in the urea cycle?

NAGS is essential for the urea cycle and its deficiency can lead to hyperammonemia.

22
New cards

What metabolic stress may severe patients experience when fed a regular diet?

They may have metabolic stress when fed a regular diet, while others may get stressed if they are ill and do not feed.

23
New cards

What symptoms can infants exhibit due to metabolic stress?

Irritability, reduced oral intake, vomiting, lethargy, and coma.

24
New cards

What are the common diagnostic methods for Urea Cycle Disorders?

Many disorders can be identified on newborn screens, biochemical testing, gene panels, and rarely, liver biopsy for enzyme analysis.

25
New cards

What is the most common deficiency associated with Urea Cycle Disorders?

Arginase deficiency.

26
New cards

What are the key features of Ornithine Transcarbamylase (OTC) Deficiency?

OTC deficiency is X-linked, presents with hyperammonemia, elevated orotic acid, and decreased citrulline and arginine.

27
New cards

What treatments are available for Ornithine Transcarbamylase Deficiency?

Standard urea cycle measures-> promote anabolism and prevent catabolism, special formula + AA, alt. pathway agents like ammonia scavengers, dialysis, plus provide citrulline or arginine.

28
New cards

Why is newborn screening for OTC deficiency considered unreliable?

Low citrulline is a poor screening test with many false positives, and patients often present before screening test results.

29
New cards

What factors can trigger hyperammonemia in patients with OTC deficiency?

Severe metabolic stress, such as steroids, bariatric surgery, large protein intake (paleo diet), and pregnancy.

30
New cards

What is the significance of variable X-inactivation in OTC deficiency?

It can lead to milder cases with later presentation and some females can present with symptoms.

31
New cards

What are the potential outcomes for patients with OTC deficiency?

Outcomes can range from neonatal death to asymptomatic cases with no orotic aciduria after protein loads.

32
New cards

What is the expected OTC activity in a patient with hyperammonemic coma at day 7?

OTC activity is typically around 12%.

33
New cards

What is a common genetic finding in OTC deficiency cases?

Full deletion of the OTC gene.

34
New cards

What is the relationship between OTC deficiency and pregnancy in female carriers?

Females who are carriers may experience complications during pregnancy.

35
New cards

What is the role of biochemical screening in OTC deficiency?

There is moderate hope for biochemical screening, with better chances for genomic screening in the future.

36
New cards

What is the typical presentation of OTC deficiency in females?

Milder cases may present with hyperammonemia only during times of severe metabolic stress.

37
New cards

What is the importance of orotic acid levels in diagnosing OTC deficiency?

Permanent orotic aciduria is a key indicator of OTC deficiency.

38
New cards

What are the implications of skewed X-inactivation in females with OTC deficiency?

It can lead to variable presentations and severity of symptoms among affected females.

39
New cards

What can happen to brothers of a patient with OTC deficiency?

Brothers may die in the neonatal period due to the disorder.

40
New cards

What is the significance of the newborn screening results for OTC deficiency?

Abnormal results may indicate a need for further testing, but low citrulline is not a reliable indicator.

41
New cards

What are the potential stressors that can exacerbate symptoms in OTC deficiency patients?

Stressors include steroids, bariatric surgery, large protein intake, and pregnancy.

42
New cards

What are the known outcomes of OTCD in pregnancy in the UK?

Out of 20 known cases, 18 resulted in live births, with 12 having a known diagnosis. 6 of these had an uncomplicated course, while 6 experienced postnatal hyperammonemia or other complications.

43
New cards

What complications did women diagnosed with OTCD face during pregnancy?

5 out of 8 women diagnosed postnatally died due to cerebral edema.

44
New cards

What is the treatment available for N-Acetyl Glutamate Synthase Deficiency?

Enzyme replacement therapy is available (Carbaglu), but it is expensive.

45
New cards

What is the genetic inheritance pattern of N-Acetyl Glutamate Synthase Deficiency?

It is an autosomal recessive disorder.

46
New cards

What are the clinical presentations of N-Acetyl Glutamate Synthase Deficiency?

It presents with hyperammonemia, and orotic acid levels are normal.

47
New cards

What is the treatment approach for Carbamoyl Phosphate Synthase Deficiency?

Treatment involves standard urea cycle measures. Provide lacking AA like citrulline, arginine, argininosuccinate.

48
New cards

What is the genetic inheritance pattern of Carbamoyl Phosphate Synthase Deficiency?

It is an autosomal recessive disorder.

49
New cards

What are the clinical features of Hyperornithinemia Hypercitrullinemia (HHH) Disease?

It presents with hyperammonemia, elevated ornithine, and the presence of homocitrulline in urine.

50
New cards

How is Hyperornithinemia Hypercitrullinemia (HHH) Disease diagnosed?

Diagnosis is made through genetic testing.

51
New cards

What is the treatment for Hyperornithinemia Hypercitrullinemia (HHH) Disease?

Treatment involves standard urea cycle measures.

52
New cards

What are the clinical features of Lysinuric Protein Intolerance?

It presents with hyperammonemia after feeding, hepatosplenomegaly, and growth failure.

53
New cards

What laboratory findings are associated with Lysinuric Protein Intolerance?

Increased lysine, arginine, and ornithine in urine, with decreased levels in plasma.

54
New cards

What is the genetic inheritance pattern of Lysinuric Protein Intolerance?

It is an autosomal recessive disorder.

55
New cards

What is the treatment for Lysinuric Protein Intolerance?

Treatment includes lysine and citrulline.

56
New cards

What is Transient Hyperammonemia of the Newborn (THAN)?

It is characterized by hyperammonemia with respiratory distress progressing to coma within the first 48 hours of life, often seen in premature infants.

57
New cards

What are the laboratory findings in Transient Hyperammonemia of the Newborn?

Ammonia levels are extremely high but return to normal within 72 hours, with all urea cycle enzymes appearing normal.

58
New cards

What is the recommended therapy for hyperammonemia in urea cycle disorders?

Therapy includes a special formula with essential amino acids, avoiding fasting, and administering IV D10+ to prevent catabolism.

59
New cards

What amino acid levels were noted in the biochemical labs for a suspected OTC deficiency?

Glutamine was 2000 (normal 100-900), Citrulline was <2 (very low), and orotic acid was elevated.

60
New cards

What genetic confirmation was found in the case presentation of suspected OTC deficiency?

A confirmed deletion of one exon of the OTC gene.

61
New cards

What is the significance of the fetus carrying the mutation in OTC deficiency?

It indicates potential implications for treatment options and management of the condition.

62
New cards

What dietary management is crucial for pregnant women with urea cycle disorders?

Strict dietary monitoring is necessary.

63
New cards

What is the role of glucose in the management of urea cycle disorders?

Glucose provides energy and helps prevent catabolism.

64
New cards

What are two alternative pathway agents used in Urea Cycle Disorders (UCDs)?

Sodium Benzoate and Sodium Phenylacetate.

65
New cards

What is Ammonul?

A combination product in IV form used in Urea Cycle Disorders.

66
New cards

When should dialysis be considered in UCD patients?

If NH3 levels exceed ~500 µmol/L.

67
New cards

What type of injury is linked to ammonia (NH3) levels?

Cerebral injury, related to NH3 level and time of exposure.

68
New cards

What are the main components of Urea Cycle Therapy?

Dialysis, diet, amino acids, and urinary excretion agents.

69
New cards

What is the role of dialysis in UCDs?

Dialysis helps remove ammonia from the body but is not a permanent solution.

70
New cards

What are some challenges of using dialysis in infants with UCDs?

Dialysis can have complications and may not be suitable for all infants.

71
New cards

How do sodium benzoate and sodium phenylbutyrate work in UCD therapy?

They act as scavengers to help reduce ammonia levels.

72
New cards

What are potential side effects of sodium benzoate and sodium phenylbutyrate therapy?

Excessive dosage can lead to complications such as metabolic acidosis.

73
New cards

What dietary considerations should be made for UCD patients?

Patients should follow a low-protein diet and avoid high-protein foods.

74
New cards

What is a common formula for UCD patients?

Specialized low-protein formulas designed for metabolic needs.

75
New cards

What is the significance of liver transplantation in treating OTC deficiency?

It is curative for OTC deficiency but may require ongoing metabolic follow-up.

76
New cards

What is the expected 5-year survival rate for liver transplantation in UCD patients?

Excellent, greater than 90% in some centers.

77
New cards

What are some complications associated with liver transplantation?

Graft failure, immunosuppression, and potential cognitive delays.

78
New cards

What experimental therapies are being studied for UCDs?

Gene therapy and mRNA therapy.

79
New cards

What is the effectiveness of newborn screening for UCDs like OTC deficiency? What are some conditions that it isnt effective for? Why?

Newborn screening has been ineffective for some urea cycle disorders. OTC, carbamoyl phosphate synthase, n-acetyl glutamate synthase, and more. Citrulline, ornithine, and arginine are all hard to detect because the normal and abnormal values overlap. example, if citrulline normal levels are 0-70 and citrulline abn levels are 0-5

80
New cards

What is the treatment of choice for Urea Cycle Disorders?

Liver transplantation.

81
New cards

What is the importance of metabolic follow-up after liver transplantation?

Some metabolic conditions may still require ongoing management.

82
New cards

What is a key point regarding presentations of Urea Cycle Disorders?

They often present similarly, but older individuals or female carriers may have varied symptoms.

83
New cards

What is the future outlook for genetic therapies in UCDs?

FDA approval of multiple genetic-based therapies is anticipated in the coming years.